The Wire · Case news
Court rulings, settlements, and case developments, with links to the source records.
Birth Injury: What Families Can Check
The FDA issued a Class I recall for the Abiomed Impella CP Set with SmartAssist (10th Generation), citing a potential for thrombus (blood clot) formation during prolonged use of the included 14Fr Low Profile Introducer Kits. A Class I recall is the most serious category, reserved for situations where use of a device may cause serious injury or death.
Source: api.fda.gov
Birth Injury: What Families Can Check
The FDA issued a Class I recall for the Abiomed Impella CP Set with SmartAssist (10th Generation), citing the potential for thrombus (blood clot) formation during prolonged use of the affected 14Fr Low Profile Introducer Kits. A Class I recall is the FDA's most serious category, indicating a reasonable probability that use of the device could cause serious injury or death.
Source: api.fda.gov
Birth Injury: What Families Can Check
The FDA announced two Class I recalls of Datex-Ohmeda infant radiant warmers — including the Panda Freestanding Warmer and the Giraffe and Panda Warmers with Integrated Resuscitation Systems — after finding that a blender knob shaft can loosen and cause the device to deliver an oxygen concentration that does not match the level set by the user. According to the FDA enforcement records, this malfunction could result in hypoxia or hyperoxia in the patient. Class I is the FDA's most serious recall classification, reserved for situations where use of the device may cause serious injury or death.
Source: api.fda.gov
Car accident claims: what to do next
Between March and July 2026, NHTSA opened at least ten vehicle safety investigations. These cover a range of concerns, including front steering knuckle fractures, rear toe link separation, automated driving system behavior, and collisions tied to Tesla's Full Self-Driving feature in low-visibility conditions. The investigations were detected by regulatory monitoring as of July 9, 2026.
Source: nhtsa.gov
Car accident claims: what to do next
Between March and July 2026, NHTSA opened at least ten vehicle safety investigations. The probes cover a range of concerns, including front steering knuckle fractures, rear toe link separation, automated driving system behavior, FSD collisions in low-visibility conditions, ABS warning lights, fuel smell and power loss, wheel fastener issues, and a rental company allegedly renting vehicles with open recalls. All signals were detected by People's Justice on July 11, 2026. Because no source URLs were provided for these signals, confidence in specific details is low.
Source: nhtsa.gov
Car accident claims: what to do next
Between March and July 2026, NHTSA opened at least ten separate vehicle safety investigations. Issues under review include collisions involving Full Self-Driving (FSD) systems in reduced visibility, front steering knuckle fractures, rear toe link separation, ABS warning light malfunctions, and a rental company allegedly renting vehicles with open recalls. These investigations were detected on July 10, 2026. All signals are low confidence due to the absence of source URLs.
Source: nhtsa.gov
Depo-Provera shots and brain tumor claims
A peer-reviewed study published July 1, 2026 in JAMA Network Open (PMID 42390859) by Hasselblad Lundstrøm N et al. reported a risk ratio of 4.5 for meningioma among users of medroxyprogesterone, a progestogen used in contraceptives including Depo-Provera. The study adds to a growing body of scientific literature examining a possible link between progestogen-based contraceptives and brain tumor development.
Source: pubmed.ncbi.nlm.nih.gov
Depo-Provera shots and brain tumor claims
A peer-reviewed study published July 1, 2026 in JAMA Network Open (PMID 42390859) by Hasselblad Lundstrøm N et al. reported a risk ratio of 4.5 for meningioma among users of the contraceptive progestogen medroxyprogesterone, the active ingredient in Depo-Provera. The study, titled 'Contraceptive Progestogens and Incident Meningioma,' adds to a growing body of scientific literature examining the relationship between progestogen-based contraceptives and brain tumor development.
Source: pubmed.ncbi.nlm.nih.gov
EtO Exposure and Cancer Claims
The U.S. Environmental Protection Agency opened enforcement case 06-2025-0910 against Denka Performance Elastomer, imposing a federal penalty of $996,703. The action was recorded in the EPA's ECHO enforcement database and detected on July 10, 2026. No additional case details, such as the specific law cited or facility address, were included in the available record.
Source: echo.epa.gov
EtO Exposure and Cancer Claims
The U.S. EPA recorded a federal penalty of $996,703 against Denka Performance Elastomer under enforcement case 06-2025-0910, according to EPA ECHO. The action was detected on July 9, 2026. No additional details about the specific law cited or filing date were included in the available record.
Source: echo.epa.gov
EtO Exposure and Cancer Claims
The U.S. Environmental Protection Agency recorded a federal penalty of $996,703 against Denka Performance Elastomer under enforcement case 06-2025-0910, according to EPA ECHO records detected on July 11, 2026. The enforcement action appears in the EPA's public compliance database. No additional details about the underlying law or filing date were included in the available record.
Source: echo.epa.gov
EtO Exposure and Cancer Claims
The U.S. Environmental Protection Agency recorded a federal penalty of $996,703 against Denka Performance Elastomer under enforcement case 06-2025-0910, according to EPA ECHO records detected on July 5, 2026. No additional details about the specific law cited or filing date were included in the enforcement record. People's Justice is an information platform, not a law firm, and this entry is provided for informational purposes only.
Source: echo.epa.gov